GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Second Sight Medical Products Inc (NAS:EYES) » Definitions » Cash Flow from Operations

Second Sight Medical Products (Second Sight Medical Products) Cash Flow from Operations : $-9.42 Mil (TTM As of Jun. 2022)


View and export this data going back to 2014. Start your Free Trial

What is Second Sight Medical Products Cash Flow from Operations?

Cash flow from operations refers to the cash brought in through a company's normal business operations. It is the cash flow before any investment or financing activities. It is the cash version of net income.

For the three months ended in Jun. 2022, Second Sight Medical Products's Net Income From Continuing Operations was $-3.08 Mil. Its Depreciation, Depletion and Amortization was $0.02 Mil. Its Change In Working Capital was $-0.17 Mil. Its cash flow from deferred tax was $0.00 Mil. Its Cash from Discontinued Operating Activities was $0.00 Mil. Its Asset Impairment Charge was $0.00 Mil. Its Stock Based Compensation was $0.01 Mil. And its Cash Flow from Others was $-0.00 Mil. In all, Second Sight Medical Products's Cash Flow from Operations for the three months ended in Jun. 2022 was $-3.22 Mil.


Second Sight Medical Products Cash Flow from Operations Historical Data

The historical data trend for Second Sight Medical Products's Cash Flow from Operations can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Second Sight Medical Products Cash Flow from Operations Chart

Second Sight Medical Products Annual Data
Trend Dec12 Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21
Cash Flow from Operations
Get a 7-Day Free Trial Premium Member Only Premium Member Only -23.95 -29.81 -27.63 -16.82 -9.19

Second Sight Medical Products Quarterly Data
Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22
Cash Flow from Operations Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -4.19 -1.80 -2.43 -1.98 -3.22

Second Sight Medical Products Cash Flow from Operations Calculation

Cash flow from operations refers to the cash brought in through a company's normal business operations. It is the cash flow before any investment or financing activities. It is the cash version of net income.

Second Sight Medical Products's Cash Flow from Operations for the fiscal year that ended in Dec. 2021 is calculated as:

Second Sight Medical Products's Cash Flow from Operations for the quarter that ended in Jun. 2022 is:


Cash Flow from Operations for the trailing twelve months (TTM) ended in Jun. 2022 adds up the quarterly data reported by the company within the most recent 12 months, which was $-9.42 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Second Sight Medical Products  (NAS:EYES) Cash Flow from Operations Explanation

For companies reported in indirect method, cash flow from operations contains six items:

1. Net Income From Continuing Operations:
Net Income From Continuing Operations indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period. It excludes extraordinary items, income from the cumulative effects of accounting changes, non-recurring items, income from tax loss carry forward, and preferred dividends.

Second Sight Medical Products's net income from continuing operations for the three months ended in Jun. 2022 was $-3.08 Mil.

2. Depreciation, Depletion and Amortization:
Depreciation is a present expense that accounts for the past cost of an asset that is now providing benefits.
Depletion and amortization are synonyms for depreciation.
Generally:
The term depreciation is used when discussing man made tangible assets
The term depletion is used when discussing natural tangible assets
The term amortization is used when discussing intangible assets

Second Sight Medical Products's depreciation, depletion and amortization for the three months ended in Jun. 2022 was $0.02 Mil.

3. Change In Working Capital:
Working Capital is a measure of a company's short term liquidity or its ability to cover short term liabilities. It is defined as the difference between a company's current assets and current liabilities. Changes in Working Capital is reported in the cash flow statement since it is one of the major ways in which net income can differ from operating cash flow.

Second Sight Medical Products's change in working capital for the three months ended in Jun. 2022 was $-0.17 Mil. It means Second Sight Medical Products's working capital declined by $0.17 Mil from Mar. 2022 to Jun. 2022 .

4. Deferred Tax:
It is the cash flow generated from deferred tax.

Second Sight Medical Products's cash flow from deferred tax for the three months ended in Jun. 2022 was $0.00 Mil.

5. Cash from Discontinued Operating Activities:
Net cash from all of the entity's discontinued operating activities.

Second Sight Medical Products's cash from discontinued operating Activities for the three months ended in Jun. 2022 was $0.00 Mil.

6. Asset Impairment Charge:
It is the charge against earnings resulting from the aggregate write down of all assets from their carrying value to their fair value.

Second Sight Medical Products's asset impairment charge for the three months ended in Jun. 2022 was $0.00 Mil.

7. Stock Based Compensation:
It is a way corporations use stock options to reward employees. It provides executives and employees the opportunity to share in the growth of the company and, if structured properly, can align their interests with the interests of the company's shareholders and investors, without burning the company's cash on hand.

Second Sight Medical Products's stock based compensation for the three months ended in Jun. 2022 was $0.01 Mil.

8. Cash Flow from Others:
These are cash differences caused by the change of inventory, accounts payable, accounts receivable etc. For instance, if a company pays its suppliers slower, its cash position will build up faster. If a company receives payments from its customers slower, its account receivables will rise, and its cash position will grow more slowly (or even shrink).

Second Sight Medical Products's cash flow from others for the three months ended in Jun. 2022 was $-0.00 Mil.


Second Sight Medical Products Cash Flow from Operations Related Terms

Thank you for viewing the detailed overview of Second Sight Medical Products's Cash Flow from Operations provided by GuruFocus.com. Please click on the following links to see related term pages.


Second Sight Medical Products (Second Sight Medical Products) Business Description

Traded in Other Exchanges
N/A
Address
13170 Telfair Avenue, Sylmar, CA, USA, 91342
Second Sight Medical Products Inc develops, manufactures, and markets implantable prosthetic devices to create an artificial form of useful vision for blind individuals. The company's product Argus II System treats outer retinal degenerations, such as Retinitis Pigmentosa, often referred to as RP. The company generates revenue from the sale of its Argus II retinal prosthesis systems, which include the implant and external components. Geographically, the company operates in the United States, Italy, China, and of which key revenue is derived from the United States.
Executives
Lisa Ellen Porter officer: Chief Medical Officer 778 CORDILLERAS AVE, SAN CARLOS CA 94070
Donald Dwyer officer: Chief Business Officer 54 CHERRY FARM LANE, WEST CHESTER PA 19382
Truc Le officer: COO 1905 WEST RED FOX ROAD, SANTA ANA CA 92704
Adam Mendelsohn director, officer: CEO C/O 5858 HORTON ST. SUITE 280, EMERYVILLE CA 94608
Brigid Makes officer: CFO 20245 SW 95TH AVENUE, TUALATIN OR 97062
Gregg Williams director, 10 percent owner PO BOX 200, WALLED LAKE MI 48390-0200
Wilford Dean Baker director 200 FLYNN ROAD, CAMARILLO CA 93012-8790
Larson Alexandra L.p. director 3797 BURNING TREE DRIVE, BLOOMFIELD HILLS MI 48302
Scott Dunbar officer: Acting CEO 13170 TELFAIR AVENUE, SYLMAR CA 91342
Edward Jonathon Sedo officer: Controller 4485 FORESTGLEN CT, MOORPARK CA 93021
Jonathan Will Mcguire director, officer: Chief Executive Officer 96 TALAMINE COURT, COLORADO SPRINGS CO 80907
Jessy Dana Dorn officer: VP-Clin & Scientific Affairs 12744 SAN FERNANDO RD. SUITE 400, SYLMAR CA 91342
Edward David Randolph officer: Vice President Manufacturing 12744 SAN FERNANDO ROAD, BLDG. 3, SYLMAR CA 91342
Matthew J Pfeffer director
Aaron Mendelsohn director 224 15TH STREET, SANTA MONICA CA 90402

Second Sight Medical Products (Second Sight Medical Products) Headlines

From GuruFocus

Second Sight Medical Products Provides Business Update

By Business Wire Business Wire 04-28-2020

Second Sight Medical Products Announces Closing of Public Offering

By Business Wire Business Wire 06-25-2021